Medtronic will acquire SPR Therapeutics for $650 million, adding the FDA-cleared SPRINT PNS System for temporary PNS to its ...

Medtronic would gain a treatment for chronic pain management in its third major acquisition this year.

Polycystic Ovary Syndrome, which has just been renamed Polyendocrine Ovarian Syndrome (PMOS), is the most common hormonal and ...

FDA conditionally approves targeted therapy for Chiari-like malformation and syringomyelia in dogs. The FDA has conditionally ...

IRB Approval Secured for PF614-MPAR-102 Part 3 ~~ Clinical Peer-Reviewed Data Published for First Overdose Protected Opioid PF614-MPAR®; Patent Estate Expanded ~~ Company Launches Formal Review of ...

There comes a point when even simple movements begin to feel heavier than they should. Climbing stairs becomes slower. Knees ...

The death of Brandon Clarke has intensified scrutiny on kratom, a controversial plant-based substance linked to health risks ...

Starting in the 1990s, people going to the doctor seeking relief for pain were often prescribed opioids, with few questions ...

Pharma stocks have been attracting FIIs. Here are three stocks where FIIs have hiked stake in the March 2026 quarter.

Migraines, joint pain and IBS affect millions of Australians over 60 — and the foods on your plate may be one of the most ...

Experts reveal which complementary treatments can help reduce pain and ease flare-ups – and which may be a waste of your ...

Think you have a food intolerance? Here are 5 foods or food groups that may be causing it. Man who went viral for remaining seated, eating appetizer as White House dinner chaos unfolded speaks out ...